Funder: National Institutes of Health (NIH)
Due Dates: May 7, 2025 | September 7, 2025 | January 7, 2026
Funding Amounts: Up to $275,000 total direct costs over 2 years, with no more than $200,000 in any single year.
Summary: Supports exploratory/developmental HIV/AIDS research related to hearing, balance, taste, smell, voice, speech, or language within NIDCD’s mission, including low-risk clinical trials.
Key Information: Applications proposing clinical trials requiring FDA oversight, high-risk trials, or NIH-defined Phase III trials are not supported under this FOA.